19 results on '"Balakirouchenane, David"'
Search Results
2. A rapid LC-MS/MS method for the simultaneous quantification of ivacaftor, lumacaftor, elexacaftor, tezacaftor, hexyl-methyl ivacaftor and ivacaftor carboxylate in human plasma
3. Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?
4. Decrease in anticortisolic drmg osilodrostat plasma exposure in patients treated with mitotane for adrenocortical carcinoma
5. Prevalence of drug–drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management
6. A Rapid Lc-Ms/Ms Method for the Simultaneous Quantification of Ivacaftor, Lumacaftor, Elexacaftor, Tezacaftor, Hexyl-Methyl Ivacaftor and Ivacaftor Carboxylate in Human Plasma
7. Decrease in anticortisolic drug osilodrostat plasma exposure in patients treated with mitotane for an adrenocortical carcinoma
8. Pharmacokinetics/Pharmacodynamics of dabrafenib and trametinib for redifferentiation and treatment of radioactive-iodine-resistant mutated advanced differentiated thyroid cancer
9. LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing’s Syndrome
10. Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma
11. Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
12. Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients
13. Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study
14. Simultaneous quantification of dabrafenib, hydroxy-dabrafenib and trametinib in human plasma by liquid chromatography-tandem mass spectrometry
15. Prevalence of Drug-Drug Interactions in Sarcoma Patients: Key Role of the Pharmacist Integration for Toxicity Risk Management
16. Pharmacogenetic—Whole blood and intracellular pharmacokinetic—Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients
17. Pharmacokinetics of Baclofen in a Full-Term Newborn after Intrauterine Exposure: A Case Report
18. Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
19. Pharmacogenetic—Whole blood and intracellular pharmacokinetic—Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.